KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Current Taxes (2016 - 2019)

Bristol Myers Squibb has reported Current Taxes over the past 11 years, most recently at $525.0 million for Q1 2019.

  • Quarterly Current Taxes rose 77.36% to $525.0 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $525.0 million through Mar 2019, up 77.36% year-over-year, with the annual reading at $398.0 million for FY2018, 72.29% up from the prior year.
  • Current Taxes was $525.0 million for Q1 2019 at Bristol Myers Squibb, up from $398.0 million in the prior quarter.
  • Over five years, Current Taxes peaked at $572.0 million in Q4 2015 and troughed at $98.0 million in Q2 2015.
  • The 5-year median for Current Taxes is $291.0 million (2017), against an average of $295.9 million.
  • Year-over-year, Current Taxes soared 118.32% in 2015 and then crashed 73.43% in 2016.
  • A 5-year view of Current Taxes shows it stood at $572.0 million in 2015, then crashed by 73.43% to $152.0 million in 2016, then soared by 51.97% to $231.0 million in 2017, then skyrocketed by 72.29% to $398.0 million in 2018, then surged by 31.91% to $525.0 million in 2019.
  • Per Business Quant, the three most recent readings for BMY's Current Taxes are $525.0 million (Q1 2019), $398.0 million (Q4 2018), and $355.0 million (Q3 2018).